Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| BiotiaQuiet$9.0M · Series A · Health & bio · New York City, NY · 2026-10-01New | BiotiaNew | Health & bio | Series A | $9.0MAmount sold on the filing of 2026-10-01 · as of 2026-10-04How this is computed → | 2026-10-01 | New York City, NY | — | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Evia BioQuiet$5.5M of $5.5M · Seed · Health & bio · 506(b) · Minneapolis, MN · 2026-09-28New | Evia BioNew | Health & bio | Seed | $5.5M of $5.5MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-04How this is computed → | 2026-09-28 | Minneapolis, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| WayBioQuiet$2.0M of $2.0M · Seed · Health & bio · 506(b) · Cambridge, MA · 2026-09-25 | WayBio | Health & bio | Seed | $2.0M of $2.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-04How this is computed → | 2026-09-25 | Cambridge, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Basecamp ResearchQuiet$140M · Series C · Health & bio · London · 2026-09-23AI-native | Basecamp ResearchAI-native | Health & bio | Series C | $140MAmount sold on the filing of 2026-09-23 · as of 2026-10-04How this is computed → | 2026-09-23 | London | — | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Basecamp ResearchQuiet$140M · Series C · Health & bio · London · 2026-09-23AI-native | Basecamp ResearchAI-native | Health & bio | Series C | $140MAmount sold on the filing of 2026-09-23 · as of 2026-10-04How this is computed → | 2026-09-23 | London | — | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| 3HelixQuiet$7.8M of $10.0M · Series A · Health & bio · 506(b) · Salt Lake City, UT · 2026-09-21 | 3Helix | Health & bio | Series A | $7.8M of $10.0MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-04How this is computed → | 2026-09-21 | Salt Lake City, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AClarity GenomicsQuiet$4.6M of $4.6M · Seed · Health & bio · 506(b) · Morrisville, NC · 2026-09-02 | AClarity Genomics | Health & bio | Seed | $4.6M of $4.6MAmount sold of the amount offered on the filing of 2026-09-02 · as of 2026-10-04How this is computed → | 2026-09-02 | Morrisville, NC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| XiltriX North AmericaQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-08-26 | XiltriX North America | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Harton TherapeuticsQuiet$15.1M of $18.1M · Series A · Health & bio · 506(b) · Melrose, MA · 2026-08-14 | Harton Therapeutics | Health & bio | Series A | $15.1M of $18.1MAmount sold of the amount offered on the filing of 2026-08-14 · as of 2026-10-04How this is computed → | 2026-08-14 | Melrose, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ORF BiologicsQuiet$1.7M of $2.5M · Seed · Health & bio · 506(b) · Tiffin, IA · 2026-07-31 | ORF Biologics | Health & bio | Seed | $1.7M of $2.5MAmount sold of the amount offered on the filing of 2026-07-31 · as of 2026-10-04How this is computed → | 2026-07-31 | Tiffin, IA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Ascendia Pharmaceutical SolutionsHiring actively$4.1M of $4.1M · Seed · Health & bio · 506(b) · North Brunswick, NJ · 2026-07-24 | Ascendia Pharmaceutical Solutions | Health & bio | Seed | $4.1M of $4.1MAmount sold of the amount offered on the filing of 2026-07-24 · as of 2026-10-04How this is computed → | 2026-07-24 | North Brunswick, NJ | 506(b) | 2The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Dash BioQuiet$30.0M of $30.0M · Series B · Health & bio · 506(b) · Boston, MA · 2026-07-14 | Dash Bio | Health & bio | Series B | $30.0M of $30.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Reticle Biosystems, Inc.Quiet$1.0M of $1.0M · Pre-seed · Health & bio · 506(b) · San Francisco, CA · 2026-07-14 | Reticle Biosystems, Inc. | Health & bio | Pre-seed | $1.0M of $1.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| PluristyxQuiet$9.8M of $14.8M · Series A · Health & bio · 506(b) · Seattle, WA · 2026-07-13 | Pluristyx | Health & bio | Series A | $9.8M of $14.8MAmount sold of the amount offered on the filing of 2026-07-13 · as of 2026-10-04How this is computed → | 2026-07-13 | Seattle, WA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Akadeum Life SciencesQuiet$2.1M of $3.4M · Seed · Health & bio · 506(b) · Ann Arbor, MI · 2026-07-09 | Akadeum Life Sciences | Health & bio | Seed | $2.1M of $3.4MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Ann Arbor, MI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |